Aethlon Medical (AEMD) Stock Analysis

What Aethlon Medical does

Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.

Key metrics

ETFs linked to AEMD

Broad-market and Healthcare sector ETFs an investor holding Aethlon Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AEMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Aethlon Medical?

Aethlon Medical trades under the ticker AEMD on NASDAQ.

Which exchange is AEMD listed on?

AEMD is listed on NASDAQ.

What sector does Aethlon Medical operate in?

Aethlon Medical is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze AEMD in a portfolio?

PortView shows AEMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.